Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06206746 · ClinicalTrials.gov registry record · NA

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

A NA study of Polycystic Ovary Syndrome and Infertility, Female, sponsored by May Health.

Recruiting
Registry status
NA
Development phase
195
Enrollment target
20
Study locations

NCT06206746: Recruiting NA study of Polycystic Ovary Syndrome and Infertility, Female, sponsored by May Health.

NCT06206746 is a NA study of Polycystic Ovary Syndrome and Infertility, Female that is actively recruiting participants, run by May Health. The registered enrollment target is 195 participants, below the 17,251-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower). The trial reports 20 study locations across 16 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06206746, a NA study of Polycystic Ovary Syndrome and Infertility, Female, is actively recruiting participants, sponsored by May Health.

RECRUITING
Registry status
NA
Development phase
195 participants
Enrollment target
20
Study locations

Study Summary

A Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue under Ultrasound Guidance in Women with Infertility due to Polycystic Ovary Syndrome

Primary Outcome

Occurrence of at least one (1) ovulation

Interventions

  • DEVICE May Health System

Study Locations (20)

California

  • HRC Fertility - Encino - Encino
  • UCSF Center for Reproductive Health - San Francisco

Florida

  • University of South Florida - Tampa
  • The IVF Center - Winter Park

North Carolina

  • Reach Fertility - Charlotte
  • UNC Fertility - Raleigh

Pennsylvania

  • Penn State College of Medicine - Hershey
  • Penn Fertility Care - Philadelphia

Arizona

  • Bloom Reproductive Institute, PLLC - Scottsdale

Illinois

  • SIU School of Medicine, Reproductive Endocrinology & Infertility Center - Springfield

Iowa

  • University of Iowa Health Care - Iowa City

Kansas

  • Cypress Medical Research Center - Wichita

Trial Details

FieldValue
Enrollment Target 195 participants
Start Date 2024-03-25
Est. Completion 2029-09
Phase NA
May Health

2 total trials

What NCT06206746 shows while recruiting

NCT06206746 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, below the 17,251-participant average among 30 other Polycystic Ovary Syndrome trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Polycystic Ovary Syndrome appearing as the primary indexed condition, and to 1 intervention - of which May Health System is the first listed.

NCT06206746 names 20 study sites across 16 states, led by California, Florida, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06206746 about?

NCT06206746 is a clinical study titled "The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System". A Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue under Ultrasound Guidance in Women with Infertility due to Polycystic Ovary Syndrome

What is the current status of trial NCT06206746?

This trial is currently recruiting. It is a NA study. The enrollment target is 195 participants. The study started on 2024-03-25. Estimated completion is 2029-09.

What conditions does trial NCT06206746 study?

This clinical trial studies the following conditions: Polycystic Ovary Syndrome, Infertility, Female.

What interventions are being tested in trial NCT06206746?

The interventions under investigation include: May Health System (DEVICE).

Who is sponsoring clinical trial NCT06206746?

This trial is sponsored by May Health, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06206746 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Polycystic Ovary Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06206746's enrollment target sits among peer trials

195 5th of 30 higher than 26 of 30 other Polycystic Ovary Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Polycystic Ovary Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04276922 · 195 participants · NA

    Creative Arts Program to Reduce Burnout in Healthcare Professionals

  • NCT04829357 · 195 participants

    Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System

  • NCT05054738 · 195 participants · NA

    CRP and S&A for Inpatient Veterans

  • NCT05561595 · 195 participants · NA

    Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06206746, the US trial registry maintained by the National Library of Medicine. NCT06206746 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.